Inhaled Nitric Oxide in Prevention/Treatment of Ischemia-Reperfusion Lung Injury Related to Lung Transplantation

NCT00060450 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

84

Enrollment

INDUSTRY

Sponsor class

Stopped Slow Enrollment

Conditions

Ischemia-Reperfusion Injury

Interventions

DRUG: nitric oxide for inhalation
DRUG: Placebo

Sponsor

Mallinckrodt